Navigation Links
New University of Toronto research a 'pore' excuse for engineering

A new study by chemists and engineers at the University of Toronto describes a nanoscale material they've created that could help satisfy society's never-ending hunger for smaller digital devices and cellphones, and could even lead to new methods for delivering medications via skin patches.

The material, known as periodic mesoporous organosilica (PMO), is a thin film interspersed with pores just two-billionths of a metre across. The team created it by mixing an organosilica precursor (silica glass, containing organic groups) with a surfactant -- essentially, a soap that mixes oil and water -- which causes the organosilica to self-assemble into a nanostructure. The scientists then washed away the surfactant to leave a nanoporous material. When they examined the thin film that remained, they discovered that it made an excellent insulator that could be used to separate tiny wires inside microelectronics.

"It demonstrates how creative chemistry can lead to really interesting engineering -- it's a good marriage," says Benjamin Hatton, who led the work while he was a PhD candidate working with both the Departments of Chemistry, with supervisor Professor Geoffrey Ozin, and Materials Science and Engineering, with supervisor Professor Doug Perovic. "Technology can develop in unexpected ways, and what we've found here could lead to developments in microelectronics or drug delivery systems."

Conventionally, computer chip manufacturers have insulated their wire connections with silica glass, preventing them from coming into contact and interfering, with each other. But the PMO film described in this study acts as a better insulator and would take up far less room, allowing components to shrink even further. "Industry is always looking for a better insulator," Hatton says. "This is an example of how materials chemistry can provide innovative solutions to the design of novel materials."


'"/>

Source:University of Toronto


Page: 1

Related biology news :

1. University of Manchester makes made-to-measure skin and bones a reality using inkjet printers
2. New protein discovered by Hebrew University researchers
3. Next Generation Body Scanner Launched By The University Of Manchester
4. Roundup®highly lethal to amphibians, finds University of Pittsburgh researcher
5. Green catalyst destroys pesticides and munitions toxins, finds Carnegie Mellon University
6. University of Nevada, Reno research team discovers hormone that causes malaria mosquito to urinate
7. Carnegie Mellon University research reveals how cells process large genes
8. University of Delaware researchers develop cancer nanobomb
9. University of Arizona plant scientists to unravel maize genome
10. Team led by Carnegie Mellon University scientist finds first evidence of a living memory trace
11. University of Utah to help build bionic arm

Post Your Comments:
(Date:11/22/2009)...ember 18, 2009 -- A butterfly,s proboscis looks li...-- but it works more like a paper towel, according...pes to borrow the tricks of this piece of insect a...uid inside of cells. , Kornev will present his w...erican Physical Society,s (APS) Division of Fluid ...
(Date:11/21/2009)...vember 20,2009 / b3c newswire / - KINAXO Biotech...cing round, gaining two new investors in the compa...NAXO reports that Jrgen Schumacher has been electe..., KINAXO shareholders Axel Ullrich, Hellmut Kirc...tutional investors Mountain Partners, BioM, High-T...
(Date:11/20/2009)...ve all read studies about the health benefits of h...e molecular level, where amino acids known as cyst...le than when paired up with other cysteines. , N...ng with colleagues in Belgium, have discovered a n...es. The research appears in the Nov. 20 issue of t...
Breaking Biology News(10 mins):KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3Saving the single cysteine: New antioxidant system found 2Derma Sciences Announces First Commercial Sales of BIOGUARD 28TM 29 Barrier Dressings 49751 1Derma Sciences Announces First Commercial Sales of BIOGUARD 28TM 29 Barrier Dressings 49751 2Derma Sciences Announces First Commercial Sales of BIOGUARD 28TM 29 Barrier Dressings 49751 3Derma Sciences Announces First Commercial Sales of BIOGUARD 28TM 29 Barrier Dressings 49751 4Biovista Inc Announces Positive Efficacy Results in a Pre Clinical Trial of its BVA 601 Repositioned Drug for Epilepsy 12744 1Biovista Inc Announces Positive Efficacy Results in a Pre Clinical Trial of its BVA 601 Repositioned Drug for Epilepsy 12744 2B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 1B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 2B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 3B Braun Medical Inc Recognized by Industry for Manufacturing Influential Medical Devices 12742 4
...xperts from Queen,s University Belfast have develo...quired infections that are resistant to antibiotic...t only kill colonies of these dangerous microbes, ... of these new antimicrobial agents was carried out...niversity Ionic Liquid Laboratories (QUILL) Resear...
...onserving Australia,s most endangered snake might ...posed. , The last remaining populations of broad-...woodland that is destroying their habitat, a study...tanford University (USA) has shown. , "Broad-head...ithin 200 km of Sydney, and those small communitie...
...IAMI University of Miami,s (UM,s) Rosenstiel Scho... announce they have received two grants totaling $...und. One award for $51,000 will be used to re-ener...ogram aboard Royal Caribbean International,s Explo...ted with ocean and atmospheric science laboratorie...
Other Biology News:Queen's scientists find new way to battle MRSA 2Australia's most endangered snake might need burning 2The University of Miami receives grants from Royal Caribbean Cruises Ltd.'s Ocean Fund 2
(Date:11/19/2009)... BLAUVELT, N.Y., Nov. 19 Dr. Mate ...xtract, responds to a press release issued on Nove...ian company for making false and self-serving stat...ces. ,, Dr. Hidvegi stated from his office in ...at research on Avemar does not apply to AveULTRA, ...
(Date:11/19/2009)... NEW YORK, Nov. 19 NeoSt...it has sent the following letter to its shareholde...er 30, 2009, of China Biopharmaceuticals Holdings,...pany based in the People,s Republic of China. The ... Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s prima...
(Date:11/19/2009)..., MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PRN...Decision Resources find that the leading driver of...urope is broad-spectrum activity against gram-posi...ty of organisms that can cause nosocomial pneumoni...ook primarily for agents that provide appropriate ...
(Date:11/19/2009)... MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeut...atient in a randomized Phase 2B study of AEG35156,...elopment for multiple oncology indications. ,, ...e 2 Study of the X-Linked Inhibitor of Apoptosis (... High-dose Cytarabine and Idarubicin in AML Follow...
Breaking Biology Technology:American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
...Hospitalist Company, Inc. (Nasdaq: IPCM ), a lead... today reaffirmed its guidance for full year 2008,... million and full year,2008 earnings per adjusted ...ncurred in the first quarter related to the Compan...ent the impact of acquisitions, the Company,typica...
...nounced today,that it received FDA 510(k) clearanc...em for Positron Emission Tomography/Computed Tomog...TM) PET Infusion System is the,first infusion syst...FDG,delivery process., (Logo: http://www.newscom...mating and controlling the FDG delivery process, t...
...reholders Believe It Reflects,Unwillingness To Con...ck of Industry Knowledge...on BetterBiovail.com All Shareholders Urged to Se... June 17 The Concerned Shareholders,of Biovail Co...a refusal by,Biovail CEO William Wells to particip...
Other Biology Technology:IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008 2IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008 3IPC The Hospitalist Company, Inc. Reaffirms Guidance for 2008 4MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System 2MEDRAD Receives FDA 510(k) Clearance for FDG Infusion System 3Biovail Concerned Shareholders Want Open Debate 2Biovail Concerned Shareholders Want Open Debate 3
Rabbit Anti-Human NIRF Polyclonal Antibody, Unconjugated from Abcam
Acc I from Invitrogen
SexA I from New England Biolabs
Psp1406 I from Takara Mirus Bio
Biology Products: